Stocks and Investing Stocks and Investing
Wed, August 31, 2022
Tue, August 30, 2022
Mon, August 29, 2022
Sun, August 28, 2022
Fri, August 26, 2022
Thu, August 25, 2022
Wed, August 24, 2022

Salim Syed Maintained (BBIO) at Strong Buy with Decreased Target to $23 on, Aug 24th, 2022


Published on 2024-10-27 22:48:33 - WOPRAI, Salim Syed
  Print publication without navigation


Salim Syed of Mizuho, Maintained "BridgeBio Pharma, Inc." (BBIO) at Strong Buy with Decreased Target from $25 to $23 on, Aug 24th, 2022.

Salim has made no other calls on BBIO in the last 4 months.



There are 2 other peers that have a rating on BBIO. Out of the 2 peers that are also analyzing BBIO, 0 agree with Salim's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Salim


  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Increased Target to $30 on, Tuesday, July 26th, 2022
  • Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $19 on, Tuesday, May 24th, 2022